Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Henning von Horsten

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Peptides|September 8, 2004
SPAG11/isoform HE2C, an atypical anionic beta-defensin-like peptideHans Henning von Horsten, Bettina Schäfer, Christiane Kirchhoff
Biology of Reproduction|August 24, 2002
Novel antimicrobial peptide of human epididymal duct originHans Henning von Horsten, Petra Derr, Christiane Kirchhoff
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fucose-targeted glycoengineering of pharmaceutical cell linesChristiane Ogorek, Ingo Jordan, Volker Sandig, et al.
Frontiers in Molecular Biosciences|September 29, 2022
Release of protein N-glycans by effectors of a Hofmann carboxamide rearrangementMumtaz Kasim, Malissa Schulz, Anja Griebel, et al.
Bioengineering (Basel, Switzerland)|September 28, 2017
Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycansGrit Sandig, Hans Henning von Horsten, Lars Radke, et al.
Bioengineering (Basel, Switzerland)|June 28, 2023
Seamless Coupling of Chemical Glycan Release and Labeling for an Accelerated Protein <i>N</i>-Glycan Sample Preparation WorkflowMumtaz Kasim, Anja Griebel, Grit Sandig, et al.
Cancer Research|March 23, 2005
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomasRonny Drapkin, Hans Henning von Horsten, Yafang Lin, et al.
Glycobiology|July 20, 2010
Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductaseHans Henning von Horsten, Christiane Ogorek, Véronique Blanchard, et al.
Bioengineering (Basel, Switzerland)|September 28, 2017
In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node ReactorLars Radke, Grit Sandig, Annika Lubitz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Peptides|September 8, 2004
SPAG11/isoform HE2C, an atypical anionic beta-defensin-like peptideHans Henning von Horsten, Bettina Schäfer, Christiane Kirchhoff
Biology of Reproduction|August 24, 2002
Novel antimicrobial peptide of human epididymal duct originHans Henning von Horsten, Petra Derr, Christiane Kirchhoff
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Fucose-targeted glycoengineering of pharmaceutical cell linesChristiane Ogorek, Ingo Jordan, Volker Sandig, et al.
Frontiers in Molecular Biosciences|September 29, 2022
Release of protein N-glycans by effectors of a Hofmann carboxamide rearrangementMumtaz Kasim, Malissa Schulz, Anja Griebel, et al.
Bioengineering (Basel, Switzerland)|September 28, 2017
Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycansGrit Sandig, Hans Henning von Horsten, Lars Radke, et al.
Bioengineering (Basel, Switzerland)|June 28, 2023
Seamless Coupling of Chemical Glycan Release and Labeling for an Accelerated Protein <i>N</i>-Glycan Sample Preparation WorkflowMumtaz Kasim, Anja Griebel, Grit Sandig, et al.
Cancer Research|March 23, 2005
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomasRonny Drapkin, Hans Henning von Horsten, Yafang Lin, et al.
Glycobiology|July 20, 2010
Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductaseHans Henning von Horsten, Christiane Ogorek, Véronique Blanchard, et al.
Bioengineering (Basel, Switzerland)|September 28, 2017
In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node ReactorLars Radke, Grit Sandig, Annika Lubitz, et al.
Pageof 1